Journal
TRENDS IN IMMUNOLOGY
Volume 29, Issue 12, Pages 616-623Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.it.2008.08.008
Keywords
-
Categories
Funding
- Spanish Ministry of Education and Science [BFU2007-64216/BMC, CSD2006-49]
- Carlos III Health Institute
Ask authors/readers for more resources
Epigenetic deregulation has become a major topic in biomedical research. Most of the information currently available in the field comes from the study of epigenetic alterations in cancer, particularly in haematological malignancies. The recognition of the epigenetic component of autoimmune diseases in conjunction with the existence of common genes underpinning pathways that are crucial to the development of autoimmunity and haematological cancers, facilitates interaction between these two areas of research. Here, we examine what is presently known from epigenetic studies of autoimmune diseases, how epigenetic alterations in haematological malignancies can be used to better understand mechanisms of epigenetic deregulation and how they might be used in epigenetic therapy to treat autoimmune diseases.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available